Qiagen discloses AFM notification on 2.99% Bank of America stake

An update from Qiagen ( (QGEN) ) is now available.

Qiagen N.V. reported that the Dutch financial regulator AFM has disclosed a new notification on voting rights related to the company, triggered by transactions on 6 May 2026 involving Bank of America Corporation and several of its affiliates. The filing shows that Bank of America holds a combined 2.99% capital and voting interest in Qiagen through a mix of ordinary shares and swap positions, all held indirectly, highlighting the continued presence of large institutional investors in the stock and offering transparency to shareholders about shifts in significant ownership stakes.

The notification details that Bank of America’s interest is split between real and potential holdings, including physically settled ordinary shares and cash-settled swaps managed through entities such as BofA Securities, Merrill Lynch International, and other affiliates. By publishing the AFM disclosure, Qiagen underscores regulatory compliance and provides the market with clarity on its shareholder structure, although it emphasizes that the accuracy of the underlying data is the responsibility of the notifying party and the AFM register.

The most recent analyst rating on (QGEN) stock is a Buy with a $49.00 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.

More about Qiagen

Qiagen N.V., based in Venlo, Netherlands, is a life sciences and diagnostics company whose shares are listed on multiple European exchanges as well as the NYSE and Swiss markets. The company focuses on molecular testing technologies used in research and clinical settings, giving it a broad international investor base and exposure to regulated capital markets.

Average Trading Volume: 2,017,406

Technical Sentiment Signal: Sell

Current Market Cap: $6.94B

See more data about QGEN stock on TipRanks’ Stock Analysis page.